Echo IQ is trading at A$0.44, up 6.02%, with no confirmed catalyst established for the session’s gain.

  • No new Echo IQ announcement dated October 22 was identified; ASX’s announcement listing showed only a BAP announcement for that date. Echo IQ’s latest listed announcement was its October 12 FDA update.
  • The FDA appeal update is earlier context, not a confirmed explanation. No clear company-specific catalyst or market-wide driver was established, leaving the reason for the gain unconfirmed.